Trial of Cyclosporine for Myocardial Protection During Open Heart Surgery (CYCLO1)
A Randomized Trial of Cyclosporine for Myocardial Protection During Open Heart Surgery
Sponsor: The University of Texas Health Science Center, Houston
Terminated
PI left institution.
Other terminated trials from The University of Texas Health Science Center, Houston
- Infantile Hemangioma · Phase PHASE4 · Jul 2025
- Smoking Cessation · Phase PHASE1 · Dec 2024
- Cluster Headache · Phase NA · May 2024
- Methamphetamine Use Disorder · Phase PHASE2 · Mar 2024
- Effect of Methadone on the Duration on Mechanical Ventilation · Phase PHASE4 · Feb 2024
See all terminations from The University of Texas Health Science Center, Houston
This PHASE1 trial investigates Cardiac Surgical Procedures and is currently terminated or withdrawn. The University of Texas Health Science Center, Houston leads this study, which shows 5 recorded versions since 2010 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE1
-
Jan 2021 — Jul 2024 [monthly]
Terminated PHASE1
-
Jun 2018 — Jan 2021 [monthly]
Terminated PHASE1
-
Jan 2017 — Jun 2018 [monthly]
Terminated PHASE1
First recorded
Apr 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- The University of Texas Health Science Center, Houston
For direct contact, visit the study record on ClinicalTrials.gov .